Donaldson (DCI) Insider: 13,500 Options Exercised and Sold on 09/03/2025
Rhea-AI Filing Summary
Guillermo Briseno, identified as an officer (President), reported transactions in Donaldson Company, Inc. (DCI) on 09/03/2025. He exercised 13,500 employee stock options with an exercise price of $28.00, producing 13,500 shares, and simultaneously sold 13,500 common shares at $79.03 per share. After these transactions the filing shows 25,309 shares beneficially owned directly.
The Form 4 notes the options were fully vested and lists an attorney-in-fact signature by Amy C. Becker dated 09/04/2025. The report is a single-person filing and discloses both the non-derivative share sale and the derivative exercise that generated the sold shares.
Positive
- Exercise of fully vested options converted compensation into shares without reported incremental grants
- Immediate sale at $79.03 realized value above the $28.00 exercise price, crystallizing gains
- Form 4 is signed by an attorney-in-fact, indicating proper execution and timely disclosure
Negative
- Beneficial ownership decreased to 25,309 shares after the sale, reducing insider-held stock
- Simultaneous sale of exercised shares removed potential alignment from retained equity
Insights
TL;DR: Routine option exercise and immediate sale realized value; net held shares decreased to 25,309.
The report documents an exercise of 13,500 employee stock options at $28.00 and an immediate sale of 13,500 shares at $79.03 on 09/03/2025. This converted equity compensation into cash at a substantial spread over the exercise price, crystallizing a per-share gross gain of $51.03 before taxes and fees. The filing shows the options were fully vested, and the transactions were executed by or on behalf of Guillermo Briseno, with beneficial ownership afterward of 25,309 shares. For investors, this is a common liquidity action by an insider converting option value to cash rather than a change in operational guidance or capital structure.
TL;DR: Standard insider exercise and sale; disclosure appears complete and signed by attorney-in-fact.
The Form 4 clearly discloses the derivative exercise and subsequent sale on the same date and notes the option cohort as fully vested. Signature by an attorney-in-fact (Amy C. Becker) dated 09/04/2025 is included, satisfying procedural filing formalities. From a governance perspective, the filing provides required transparency on officer transactions but contains no additional governance events such as resignations, new grants, or change-in-control triggers.